Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Dow Jones Industrial Average ETF (DIA) vs Smith & Nephew plc (SNN) Price & Performance

Dow Jones Industrial Average ETFTrade
Smith & Nephew plcTrade

Price performance (Past 24H)

Key statistics

Dow Jones Industrial Average ETF vs Smith & Nephew plc — how do they compare? Dow Jones Industrial Average ETF trades at $537.8, while Smith & Nephew plc trades at $29.77 (market cap $12.54B). The key difference: Smith & Nephew plc pays a 2.65% dividend while Dow Jones Industrial Average ETF pays none, and Dow Jones Industrial Average ETF is trading nearer its 52-week high, Smith & Nephew plc nearer its low. Which is the better fit depends on your goals.

DIASNN
52-Week High
$542.79$38.70
52-Week Low
$444.64$28.73
Market Cap
$12.54B
Sector
Health
Enterprise Value
$15.57B
Dividend Yield
2.65%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Dow Jones Industrial Average ETF

DIA trades at $537.63, down 0.25% on the day, with a bullish technical signal driven by moving averages. The stock is near its pivot point of $539, with support at $536 and resistance at $540. Recent dividends include H1-26 payments of $1.41 and $0.28, with another $0.15 scheduled for H2-26.

The outlook is supported by broad market momentum and defensive ETF inflows, though overbought RSI levels suggest near-term caution. Key risks include market volatility and interest rate sensitivity. Analyst sentiment is generally positive given the Dow's performance and institutional interest in blue-chip exposure.

Smith & Nephew plc

Smith & Nephew (SNN) trades at $29.76, down 1.06% with bearish technical signals. The company shows improving fundamentals with revenue growth from $5.8B to $6.2B and net income margin expanding to 10.08% in 2025. Recent Q2 2026 earnings beat expectations but the company lowered full-year revenue guidance from 6% to 4% growth due to U.S. Orthopaedics weakness.

While valuation multiples appear reasonable (P/E 20.41, EV/EBITDA 9.9), the stock faces headwinds from mixed earnings performance and cautious analyst sentiment. The primary investment case hinges on execution in robotics and wound care segments offsetting orthopedic challenges, with downside risk from continued U.S. market softness.

Returns comparison

Trailing returns across standard periods

About Dow Jones Industrial Average ETF

The ETF is designed to track the performance of the securities and the stocks in the Dow Jones Industrial Average Index. To maintain the composition and weightings, the advisor adjusts the ETF from time to time to conform to periodic changes in the index target.

Read more on DIA

About Smith & Nephew plc

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Read more on SNN